固体瘤瘤学中药物诱导的皮肤毒性:机制,表现和管理
Vladislav Skossyrskiy1, Maxim Boot2, Igor Gadaev2
1Sechenov First Moscow State Medical University, Moscow, Russia. skosyrskiy_v@staff.sechenov.ru.
Medical oncology (Northwood, London, England)
|December 11, 2025
概括
癌症疗法经常导致皮肤毒性,影响患者的生活质量. 本综述详细介绍了抗癌药物的副作用,它们的机制以及固体瘤的管理策略.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮肤毒性是癌症治疗的常见和可见的副作用.
- 它显著影响患者的生活质量,治疗坚持和剂量强度.
- 了解这些皮肤学不良事件对于有效的癌症治疗至关重要.
研究的目的:
- 审查关于固体瘤中抗癌剂皮肤毒性的机制,临床表现和管理的当前知识.
- 整合各种药物类别的数据,包括向疗法和免疫疗法.
- 为预防和管理提供实用,基于机制的预防和管理战略.
主要方法:
- 叙事审查综合现有文献.
- 整合不同类型的抗癌药物数据 (例如EGFR抑制剂,税,ICI,CAR T细胞疗法).
- 专注于机制,临床模式和管理策略.
主要成果:
- 皮肤毒性源于皮肤平衡中断,瘤性通路激活,免疫炎症或内皮损伤.
- 临床表现包括各种喷发,,,手脚综合征,指甲变化和罕见的严重反应.
- 由于与年龄相关的皮肤变化和并发症,老年人特别容易受到伤害.
结论:
- 有效的管理包括基本的皮肤护理,光保护和针对性治疗,如抗生素和皮质类固醇.
- 及时识别和多学科护理对于维持治疗效果和生活质量至关重要.
- 需要进一步的研究,特别是对于老年人等弱势群体.
相关概念视频
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Skin Diseases and Disorders
5.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K


![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)